HomeUTHR • NASDAQ
add
United Therapeutics Corp
Nakaraang pagsara
$437.33
Sakop ng araw
$432.53 - $446.08
Sakop ng taon
$266.98 - $479.50
Market cap
19.16B USD
Average na Volume
713.84K
P/E ratio
16.85
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 799.50M | 6.76% |
Gastos sa pagpapatakbo | 309.30M | 20.07% |
Net na kita | 338.70M | 9.58% |
Net profit margin | 42.36 | 2.64% |
Kita sa bawat share | 7.16 | 1.25% |
EBITDA | 411.20M | -3.77% |
Aktuwal na % ng binabayarang buwis | 22.67% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.77B | -16.80% |
Kabuuang asset | 7.35B | 3.20% |
Kabuuang sagutin | 760.90M | -25.56% |
Kabuuang equity | 6.59B | — |
Natitirang share | 43.06M | — |
Presyo para makapag-book | 2.85 | — |
Return on assets | 12.76% | — |
Return on capital | 14.14% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 338.70M | 9.58% |
Cash mula sa mga operasyon | 562.10M | 49.02% |
Cash mula sa pag-invest | 140.90M | 222.63% |
Cash mula sa financing | -956.00M | -1,391.42% |
Net change in cash | -253.00M | -227.65% |
Malayang cash flow | 157.44M | -36.60% |
Tungkol
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Itinatag
1996
Headquarters
Website
Mga Empleyado
1,305
